Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Frontiers in Genetics|February 18, 2021
CDK6 Is a Potential Prognostic Biomarker in Acute Myeloid LeukemiaWei Liu, Jin-Mou Yi, Yi Liu, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|February 7, 2020
Effects of Trough Concentration and Solute Carrier Polymorphisms on Imatinib Efficacy in Chinese Patients with Chronic Myeloid LeukemiaQing Wang, Zhi-Ping Jiang, Jing Zeng, et al.
Life Sciences|February 28, 2020
Down-regulating NQO1 promotes cellular proliferation in K562 cells via elevating DNA synthesisFei-Yan Xiao, Zhi-Ping Jiang, Fang Yuan, et al.
Journal of Hematology & Oncology|July 25, 2020
Roles of hsa-miR-12462 and SLC9A1 in acute myeloid leukemiaYan Jia, Wei Liu, Hui-En Zhan, et al.
Pharmacogenomics|February 16, 2019
Population pharmacokinetic and pharmacogenetics of imatinib in Chinese patients with chronic myeloid leukemiaQing Wang, Zhi-Ping Jiang, Er-Qian Yu, et al.
European Journal of Pharmacology|January 21, 2021
TBC1D16 predicts chemosensitivity and prognosis in adult acute myeloid leukemia (AML) patientsHan Liu, Peng Chen, Yong-Long Yang, et al.
Journal of Translational Medicine|July 19, 2018
Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimensPeng Chen, Ke-Wei Zhu, Dao-Yu Zhang, et al.
Journal of Translational Medicine|July 12, 2019
Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patientsXiao-Qing Yuan, Peng Chen, Yin-Xiao Du, et al.
Pageof 4